Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia — eve-1  

Presbyopia Clinical Trial

Official title: Pilot Clinical Investigation of Adaptive Eyeglasses for the Correction of Presbyopia

Status Completed

Clinical Trial Summary

This study is a pilot clinical investigation of adaptive eyeglasses for the correction of presbyopia. The goal of this clinical investigation is to assess IMD safety and to obtain patient feedback on the usefulness of the Laclarée eyeglasses, through subjective clinical measures and qualitative evaluations. This is an exploratory investigation.

Clinical Trial Description

Presbyopia is a visual impairment caused by the normal aging of the eye lens and resulting in progressive loss of accommodation. As a consequence, from the onset of presbyopia occurring around 40-45 years old, the eye has growing trouble focusing at near and intermediate distances. Millions of presbyopes encounter difficulties with current corrective solutions, leading to vision and postural discomfort. Laclarée's adaptive eyeglasses are providing an alternative solution, closer to the native crystalline accommodation. Besides an enhanced field-of-view, these eyeglasses offer a disruptive ergonomics where the glasses automatically adjust to the wearer's need to provide clear vision at all distances and can be electronically recalibrated to adjust the delivered addition throughout presbyopia. ;

Related Conditions & MeSH terms

• Presbyopia

• NCT number: NCT05326607
• Study type: Interventional
• Source: Laclaree
• Status: Completed
• Phase: N/A
• Start date: September 9, 2021
• Completion date: January 27, 2022